Figure 4.
NOX2-deleted AMs acquire epigenetic alterations. (A) An MDS plot of AM ATAC-seq peak signals in 2 different dimensions showing differences among the indicated groups of mice (n = 3 independent samples in each group). (B) Histogram comparing aggregate ATAC-seq peak heights around TSSs (±500 kb) in various groups for the genes with significant differences between CybbKO CD11bhigh AMs and WT CD11blow AMs from 12-week-old mice. (C) Venn diagram showing the overlay of genes with significant alterations in both RNA-seq and ATAC-seq (TSS, ±500 kb) among various groups. (D) Representative WUSTL epigenome browser tracks displaying normalized ATAC-seq peak signal distribution in selected genes from AMs sampled from the indicated groups of 4- and 12-week-old WT and CybbKO mice along with CHIP-seq data for H3K4Me1 and H3K27ac marks from Lavin et al.58 Boxes indicate ATAC-seq peaks that are significantly different in 12-week-old CybbKO samples compared with 12-week-old WT samples. (E) Hallmark gene set analysis for genes with altered ATAC-seq peak signals between CybbKO CD11bhigh and WT CD11blow as well as CybbKO CD11bhigh and CybbKOCD11blowAMs. (F) HOMER de novo motif enrichment analysis for transcription factor binding sites in open chromatin ±500 kb from the TSS, as identified in ATAC-seq, as analyzed in AMs sampled from 12-week-old mice (n = 3 independent samples in each group). The percentage of motif occurrence in peaks vs background is also shown. CHIP, chromatin immunoprecipitation; HOMER, hypergeometric optimization of motif enrichment; MDS, multidimensional scaling; TSS, transcription start site.